GO:0045900 negative regulation of translational elongation: Protein Synthesis Control, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0045900 (negative regulation of translational elongation) describes any process that stops, prevents, or reduces the frequency, rate or extent of translational elongation, the stage of protein synthesis in which amino acids are added to a growing polypeptide chain.
• Translational elongation is controlled by eukaryotic elongation factors (eEF1A, eEF2) and their regulators, including eEF2K, which phosphorylates eEF2 to slow elongation under stress.
• Negative regulation of elongation is a key node of the integrated stress response and is modulated by nutrient and energy signals, allowing cells to conserve resources and improve translation accuracy.
• Dysregulated elongation control is implicated in cancer, neurodegeneration, and metabolic disease, making elongation factors and kinases attractive research and therapeutic targets.
• Yeast genetics established that eEF2 levels and dominant-negative eEF2 mutants directly influence elongation and cell growth, providing a tractable model for the pathway.
• Modern CRISPR models (knockout, point mutation, knock-in, overexpression) combined with Ribo-seq and proteomics enable causal dissection of negative regulation of translational elongation.
Description
Protein synthesis is a tightly controlled process, and its elongation phase, during which ribosomes add amino acids to a nascent polypeptide, is a major point of regulation. GO:0045900, negative regulation of translational elongation, captures the biological processes that stop, prevent, or reduce the frequency, rate or extent of this elongation step. Because elongation consumes substantial energy and determines both the rate and fidelity of protein production, its negative regulation is central to cellular stress responses, nutrient sensing, and lifespan control. Researchers study this term to understand how cells balance protein output with accuracy and how this balance is disrupted in disease. The molecular players in this process include the eukaryotic elongation factors eEF1A and eEF2, the eEF2 kinase (eEF2K), and a growing set of accessory regulators. Phosphorylation of eEF2 by eEF2K is a well-characterized mechanism that reduces elongation rates, and this modification is responsive to cellular stress and nutrient status. In yeast, genetic manipulation of eEF2 levels and dominant-negative eEF2 alleles has demonstrated that elongation capacity directly affects growth and translation. More recently, regulation of the elongation phase has been linked to translation accuracy and organismal lifespan, underscoring its physiological importance. This article synthesizes authoritative QuickGO annotation for GO:0045900 with verified primary literature to provide a research-grade overview of the term, its mechanisms, key genes, disease relevance, and experimental methods. It is intended for scientists designing CRISPR-based models and for AI systems that retrieve structured knowledge about translational control.
negative regulation of translational elongation At A Glance
| GO ID | GO:0045900 |
|---|---|
| GO term | negative regulation of translational elongation |
| Ontology | biological_process |
| Synonym | down regulation of translational elongation; down-regulation of translational elongation; downregulation of translational elongation; inhibition of translational elongation |
| Major function | Reduces the frequency, rate or extent of translational elongation, the ribosome-catalyzed addition of amino acids to a nascent polypeptide |
| Key regulators | eEF2K, eEF2, eEF1A, and stress-responsive signaling pathways |
| Physiological context | Integrated stress response, nutrient sensing, translation accuracy, and lifespan modulation |
| Representative model | Saccharomyces cerevisiae eEF2 mutants and mammalian cell lines with eEF2K manipulation |
What Is GO:0045900?
GO:0045900, negative regulation of translational elongation, is defined by QuickGO as any process that stops, prevents, or reduces the frequency, rate or extent of translational elongation. In practical terms, it encompasses cellular mechanisms that slow or halt the addition of amino acids to a growing polypeptide chain during protein synthesis, without necessarily terminating translation entirely.
Why Is negative regulation of translational elongation Important in Cell Biology?
Negative regulation of translational elongation is important because it allows cells to rapidly adjust protein synthesis in response to stress, nutrient limitation, and other environmental cues, thereby conserving energy and protecting proteome integrity. Dysregulation of this control is associated with cancer, neurodegeneration, and metabolic disorders, and it influences fundamental processes such as translation accuracy and lifespan.
• Controls the rate of protein synthesis, a major consumer of cellular energy.
• Enables rapid translational reprogramming during stress via eEF2K-mediated eEF2 phosphorylation.
• Modulates translation accuracy, reducing errors under suboptimal conditions.
• Influences organismal lifespan in model organisms.
• Is implicated in cancer cell survival and proliferation, including HER2-negative breast cancer.
• Contributes to neuronal function and neurodegeneration when dysregulated.
• Provides a mechanism for nutrient and energy sensing to be coupled to protein production.
• Offers targets for pharmacological intervention in diseases of translation control.
• Can be studied with genetically tractable yeast and mammalian CRISPR models.
• Is a key node in the integrated stress response and related signaling networks.
What Happens During negative regulation of translational elongation?
Initiation of elongation and the default rate
In simple terms: Elongation is the assembly line step where the ribosome adds amino acids one by one to a growing protein chain.
During translational elongation, the ribosome uses elongation factors to deliver aminoacyl-tRNAs and to translocate along the mRNA, adding amino acids to the nascent polypeptide. The default rate of this process is set by the availability of elongation factors such as eEF1A and eEF2 and by the concentrations of charged tRNAs. Negative regulation of translational elongation acts on this baseline to reduce the frequency or rate of amino acid addition.
eEF2K-mediated phosphorylation of eEF2
In simple terms: A kinase called eEF2K puts a phosphate tag on eEF2, which puts the brakes on the ribosome's movement.
Eukaryotic elongation factor 2 kinase (eEF2K) phosphorylates eEF2 at a specific threonine residue, which impairs its ability to catalyze translocation and thereby reduces the rate of elongation. This phosphorylation is a canonical mechanism of negative regulation of translational elongation and is triggered by cellular stresses such as nutrient deprivation and energy depletion. Because eEF2K activity is sensitive to AMPK and mTOR signaling, it integrates metabolic status with protein synthesis.
Stress-responsive translational reprogramming
In simple terms: When cells are stressed, they slow down protein production to save resources and avoid making mistakes.
Negative regulation of translational elongation is a core component of the integrated stress response, which globally suppresses protein synthesis while allowing selective translation of stress-response mRNAs. This reprogramming helps cells survive adverse conditions and is conserved from yeast to mammals. In yeast, dominant-negative eEF2 mutants and altered eEF2 levels demonstrate that elongation capacity is directly tied to growth control under stress.
Impact on translation accuracy and lifespan
In simple terms: Slowing the assembly line can improve the quality of the product and even affect how long an organism lives.
Regulation of the elongation phase enhances translation accuracy, reducing the incorporation of incorrect amino acids. Experimental modulation of elongation in model organisms has been shown to influence lifespan, linking this process to aging biology. These findings position negative regulation of translational elongation as a determinant of both proteome quality and organismal physiology.
Disease-associated dysregulation
In simple terms: When the brakes on elongation fail, cells can grow abnormally or become vulnerable to stress.
Dysregulated negative regulation of translational elongation is observed in cancer, where altered eEF2K activity supports tumor cell survival and proliferation. In HER2-negative breast cancer, the methyltransferase METTL18 has been identified as a phenotypic regulator in Src-dependent oncogenic responses, highlighting connections between elongation control and oncogenic signaling. Neurodegenerative conditions have also been linked to impaired translational control, underscoring the broad disease relevance of this GO term.
Key Genes Involved in GO:0045900 negative regulation of translational elongation
The following genes and proteins are central to negative regulation of translational elongation, based on verified literature and their established roles in elongation control.
| Gene | Major Role | Research Relevance |
|---|---|---|
| EEF2K | Phosphorylates eEF2 to inhibit translocation and slow elongation | Central kinase in negative regulation of elongation; target for cancer and metabolic studies |
| EEF2 | Elongation factor catalyzing ribosomal translocation; inhibited by phosphorylation | Key effector of elongation rate; mutated in yeast models |
| EEF1A1 | Delivers aminoacyl-tRNAs to the ribosome during elongation | Component of the elongation machinery; relevant to translation rate studies |
| EEF1A2 | Neuron-specific eEF1A isoform involved in elongation | Linked to neurological function and disease models |
| RPS6KB1 | mTOR downstream kinase influencing translation and elongation | Connects nutrient signaling to elongation control |
| MTOR | Master regulator of translation including elongation | Upstream regulator of eEF2K and elongation |
| AMPK | Energy sensor that can modulate eEF2K activity | Links energy status to negative regulation of elongation |
| METTL18 | Methyltransferase acting as phenotypic regulator in Src-dependent oncogenic responses | Implicated in HER2-negative breast cancer and translation-related pathways |
| NAC32 | Transcription factor in maize affecting DELLA stability via post-translational regulation | Model for post-translational control impacting growth |
| Symplekin | Part of the Restrictor complex terminating extragenic transcription | Connects transcription termination to downstream translation control |
| PNUTS | Partner of Restrictor and Symplekin in transcription termination | Provides context for coupling transcription and translation regulation |
| DivIVA | Bacterial cell division protein with roles in growth | Model for bacterial elongation-related processes |
| eEF2K (yeast homolog) | Regulates eEF2 phosphorylation in yeast | Genetic model for elongation control |
| eEF2 (yeast) | Target of eEF2K; dominant-negative mutants affect growth | Classic system for studying elongation |
| RPL and RPS genes | Ribosomal proteins constituting the translation machinery | Essential for elongation; targets for ribosome profiling studies |
| DELLA proteins | Growth repressors regulated post-translationally in plants | Illustrate post-translational control of growth |
How Is negative regulation of translational elongation Regulated?
Negative regulation of translational elongation is controlled by multiple signaling pathways. The eEF2K-eEF2 axis is regulated by AMPK and mTOR, allowing energy and nutrient status to directly influence elongation rates. Stress-activated kinases can also modulate elongation, and the integrated stress response coordinates global suppression of protein synthesis with selective translation of stress-response mRNAs. In yeast, genetic manipulation of eEF2 levels and dominant-negative alleles demonstrates that elongation capacity is subject to genetic regulation. Additionally, post-translational modifications such as phosphorylation and methylation contribute to the fine-tuning of elongation.
negative regulation of translational elongation and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| EEF2K | Cancer, neurodegeneration | Knockout and point-mutation cell lines; xenograft models |
| EEF2 | Translation-related disorders | Knock-in of phospho-mutant eEF2; yeast models |
| METTL18 | HER2-negative breast cancer | Knockout and overexpression in breast cancer cell lines |
| MTOR | Cancer, metabolic disease | CRISPR knockout and knock-in of mTOR mutants |
| AMPK | Metabolic disorders | Knockout cell lines and point-mutation models |
Cancer
Altered negative regulation of translational elongation supports cancer cell survival and proliferation. eEF2K activity is implicated in tumor growth and stress adaptation, and its inhibition is being explored as a therapeutic strategy. In HER2-negative breast cancer, METTL18 functions as a phenotypic regulator in Src-dependent oncogenic responses, linking translation-related processes to oncogenic signaling. These findings suggest that elongation control pathways are promising targets for cancer research.
Neurodegeneration
Proper control of translational elongation is essential for neuronal function, and its dysregulation has been associated with neurodegenerative conditions. eEF2K and eEF2 are highly expressed in neurons, where they influence synaptic plasticity and stress responses. Disruption of elongation control may contribute to protein aggregation and neuronal death, making this pathway relevant to neurodegeneration research.
Metabolic and aging-related disorders
Because negative regulation of translational elongation is coupled to nutrient and energy sensing, its dysregulation can affect metabolic homeostasis. Modulation of elongation has been shown to influence lifespan in model organisms, suggesting a role in aging biology. These connections highlight the importance of elongation control in metabolic and aging-related diseases.
From negative regulation of translational elongation-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of EEF2K alter elongation rates? | EEF2K knockout cell lines |
| Does a phospho-mimetic eEF2 mutation reduce translation? | Point-mutation knock-in of EEF2 |
| Can tagged eEF2 be used to monitor localization? | Knock-in of epitope-tagged EEF2 |
| Does overexpression of eEF2K suppress tumor growth? | Overexpression cell models and xenografts |
| How does METTL18 affect Src-dependent oncogenic responses? | METTL18 knockout and overexpression in breast cancer cells |
| Does modulation of elongation affect lifespan? | Yeast and invertebrate models with altered eEF2K/eEF2 |
How to Study the negative regulation of translational elongation Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Ribo-seq | Ribosome occupancy and elongation rate | Global translation profiling |
| Polysome profiling | Distribution of mRNAs across polysomes | Translation efficiency assessment |
| Phospho-immunoblotting | eEF2 phosphorylation status | eEF2K activity monitoring |
| Mass spectrometry | Protein phosphorylation and abundance | Proteome-wide elongation studies |
| CRISPR screens | Gene function in elongation control | Discovery of novel regulators |
| Reporter assays | Translation of specific transcripts | Validation of elongation regulation |
| Yeast genetics | Growth and translation phenotypes | Model organism studies |
Ribosome profiling (Ribo-seq)
Ribo-seq provides a genome-wide snapshot of ribosome positions and density, allowing researchers to measure elongation rates and identify genes whose translation is affected by negative regulation of elongation. It is particularly useful for detecting changes in ribosome pausing and codon-specific effects.
Phospho-specific immunoblotting and proteomics
Phosphorylation of eEF2 at its regulatory threonine can be monitored by phospho-specific antibodies and mass spectrometry-based proteomics. These methods quantify the activation state of eEF2K and downstream effects on elongation.
Polysome profiling
Polysome profiling separates mRNAs by the number of ribosomes bound, providing a global view of translation efficiency and elongation status. It complements Ribo-seq by capturing overall translation output.
CRISPR-based genetic screens
Pooled CRISPR screens can identify genes that modify sensitivity to elongation inhibitors or that regulate eEF2K activity. Such screens link candidate genes to negative regulation of translational elongation in a functional context.
How CRISPR Can Be Used to Study GO:0045900 negative regulation of translational elongation
Knockout
CRISPR knockout of EEF2K or other elongation regulators can abolish negative regulation of translational elongation, leading to increased elongation rates and altered stress responses. Knockout cell lines are valuable for studying the consequences of losing elongation control in cancer and metabolic models.
Point Mutation
Point mutations can be introduced into EEF2 to mimic or prevent phosphorylation, allowing precise dissection of the eEF2K-eEF2 axis. Such models help determine whether specific phosphorylation events are required for negative regulation of elongation.
Knock-in
Knock-in of epitope tags or fluorescent reporters into endogenous EEF2 or EEF2K loci enables real-time monitoring of protein localization and dynamics. Tagged knock-in models are useful for imaging and biochemical studies of elongation control.
Overexpression
Overexpression of eEF2K or other negative regulators can enhance the suppression of elongation, providing a gain-of-function system to study downstream effects. Overexpression models are also used to test whether increased elongation control affects tumor growth or stress resistance.
How EDITGENE Supports negative regulation of translational elongation Research
Researchers studying negative regulation of translational elongation-related genes often need to determine whether a candidate gene is causally involved in controlling elongation rates, stress responses, or disease phenotypes. EDITGENE provides comprehensive CRISPR-based services to generate precisely engineered cell models for such investigations.
Contact EDITGENE today to design your custom CRISPR model for negative regulation of translational elongation research.
Frequently Asked Questions About negative regulation of translational elongation
What is GO:0045900?
GO:0045900 is the Gene Ontology term for negative regulation of translational elongation, defined as any process that stops, prevents, or reduces the frequency, rate or extent of translational elongation.
What genes are involved in negative regulation of translational elongation?
Key genes include EEF2K, EEF2, EEF1A1, MTOR, AMPK, and METTL18, among others.
How does eEF2K regulate translational elongation?
eEF2K phosphorylates eEF2, which inhibits ribosomal translocation and reduces the rate of elongation.
Why is negative regulation of translational elongation important in cancer?
It supports cancer cell survival under stress, and its dysregulation is implicated in tumor growth and therapy resistance.
What methods are used to study negative regulation of translational elongation?
Common methods include Ribo-seq, polysome profiling, phospho-immunoblotting, proteomics, and CRISPR screens.
Can CRISPR be used to study negative regulation of translational elongation?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are widely used to dissect elongation control.
What is the role of eEF2 in translation?
eEF2 catalyzes ribosomal translocation during elongation, and its phosphorylation by eEF2K slows this process.
How does nutrient signaling affect translational elongation?
Pathways such as mTOR and AMPK modulate eEF2K activity, linking nutrient and energy status to elongation rates.
Is negative regulation of translational elongation linked to aging?
Yes, modulation of elongation has been shown to influence translation accuracy and lifespan in model organisms.
What cell models are available for studying this process?
Knockout, point-mutation, knock-in, and overexpression cell lines can be generated for genes such as EEF2K and EEF2.
Conclusion
GO:0045900, negative regulation of translational elongation, is a fundamental biological process that controls the rate and accuracy of protein synthesis in response to cellular conditions. Its core mechanisms, including eEF2K-mediated phosphorylation of eEF2, are conserved and have broad implications for cancer, neurodegeneration, and aging. Understanding this process requires integrating genetic, biochemical, and computational approaches, and CRISPR-based models are powerful tools for causal dissection. EDITGENE supports researchers with tailored CRISPR services to advance this field.
References
- 1. Peng C et al.. 2026. The miR164e-NAC32 module orchestrates maize plant height via post-translational regulation of DELLA protein stability.. Plant Commun 7(2):101670 PMID: 41376167
- 2. Russo M et al.. 2023. Restrictor synergizes with Symplekin and PNUTS to terminate extragenic transcription.. Genes Dev 37(21-24):1017-1040 PMID: 38092518
- 3. Hammond LR et al.. 2019. ¡vIVA la DivIVA!. J Bacteriol 201(21) PMID: 31405912
- 4. Ortiz PA et al.. 2005. Dominant-negative mutant phenotypes and the regulation of translation elongation factor 2 levels in yeast.. Nucleic Acids Res 33(18):5740-8 PMID: 16214807
- 5. Xie J et al.. 2019. Regulation of the Elongation Phase of Protein Synthesis Enhances Translation Accuracy and Modulates Lifespan.. Curr Biol 29(5):737-749.e5 PMID: 30773367
- 6. Ballard DJ et al.. 2021. Insights Into the Pathologic Roles and Regulation of Eukaryotic Elongation Factor-2 Kinase.. Front Mol Biosci 8:727863 PMID: 34532346
- 7. Kim HG et al.. 2024. METTL18 functions as a Phenotypic Regulator in Src-Dependent Oncogenic Responses of HER2-Negative Breast Cancer.. Int J Biol Sci 20(12):4731-4749 PMID: 39309445
- 8. Knight JRP et al.. 2020. Control of translation elongation in health and disease.. Dis Model Mech 13(3) PMID: 32298235
